EKF Diagnostics Investor Announcements
EKF Diagnostics Holdings plc is an in-vitro diagnostics (IVD) business. The Company is engaged in the designing, development, manufacture and selling of diagnostic analyzers, reagents and ancillary products. This activity takes place across several geographical locations which include the United Kingdom, United States of America, Germany, Poland and Russia.
EKF Diagnostics Holdings plc announces a trading update for the year ended 31 December 2015.
EKF Diagnostics Holdings plc announces that it has reached agreement to sell its wholly owned subsidiary Selah Genomics, Inc.
EKF Diagnostics Holdings announces that it has reached agreement to borrow £3 million by way of convertible loan from Zwanziger Family Ventures LLC.
EKF Diagnostics Holdings plc is pleased to announce that Lurene Joseph joins the Board as a non-executive director with immediate effect.
Share purchase by Paul Foulger, outgoing Finance Director.
EKF announces its Chief Technology Officer has resigned from the Board with immediate effect.